Their study suggested several potential mechanisms for the reduced ADAMTS13 levels in DN patients, including decreased synthesis due to the inflammatory environment, proteolytic degradation by increased plasma proteases such as thrombin and plasmin, and the loss of ADAMTS13 in the urine due to kidney dysfunction [43]. This evidence concerns the gene PLG and liver dysplastic nodule.